Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
2rX03bdZ6dfJNqP5
Listen
